Rivastigmine Capsules in Patients With Probable Vascular Dementia

Completed

Phase 3 Results N/A

Summary of Purpose

The goal of this research study is to evaluate, in the open-label extension phase, the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 November 2011.

1 Feb 2002 11 Aug 2005 1 May 2006 1 May 2006 1 Nov 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available